Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.38 |
| ▸ | TYMP | P19971 | 1/20 | 0.38 |
| ▸ | TK2 | O00142 | 1/20 | 0.36 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4859519 | 1.00 | TK1 (0.38) | TK1TYMPTK2RNASE1 | |
| SCHEMBL6710613 | 1.00 | TK1 (0.38) | TK1TYMPTK2RNASE1 | |
| SCHEMBL4859530 | 1.00 | TK1 (0.38) | TK1TYMPTK2RNASE1 | |
| SCHEMBL6710611 | 1.00 | TK1 (0.38) | TK1TYMPTK2RNASE1 | |
| SCHEMBL6711454 | 0.81 | KMT2A (0.33) | — | |
| SCHEMBL6711457 | 0.81 | KMT2A (0.33) | — | |
| SCHEMBL4858232 | 0.78 | TK1 (0.45) | TK1TYMP | |
| SCHEMBL6717375 | 0.76 | HPRT1 (0.42) | — | |
| SCHEMBL6717369 | 0.76 | HPRT1 (0.42) | — | |
| SCHEMBL4849546 | 0.76 | KMT2A (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1049678-B1 | CYCLOHEXYL AND HETEROCYCLYL NUCLEOSIDE DERIVATIVES, METHOD FOR PRODUCING THESE DERIVATIVES, AND THE USE OF THE DERIVATIVES AND THEIR OLIGOMERS OR CONJUGATES IN PAIRING AND/OR TESTING SYSTEMS | SANOFI SA (FR) | 2012-10-24 | — | — | EP | claimed |
| EP-1049678-B1 | CYCLOHEXYL AND HETEROCYCLYL NUCLEOSIDE DERIVATIVES, METHOD FOR PRODUCING THESE DERIVATIVES, AND THE USE OF THE DERIVATIVES AND THEIR OLIGOMERS OR CONJUGATES IN PAIRING AND/OR TESTING SYSTEMS | SANOFI SA (FR) | 2012-10-24 | — | — | EP | disclosed |
| US-7439345-B2 | Supramolecular pairing system, its preparation and use | NANOGEN RECOGNOMICS GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20040142451-A1 | Supramolecular pairing system, its preparation and use | NANOGEN RECOGNOMICS GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
| US-6689884-B1 | Supramolecular pairing system, its preparation and use | NANOGEN RECOGNOMICS GMBH (DE) | 2004-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142451-A1 | Supramolecular pairing system, its preparation and use | TIMCC, MTCL3, UACA | TK1 2926/4885TYMP 1912/4885TK2 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.